Shares of Medtronic PLC MDT were unchanged Monday, on what proved to be an all-around mixed trading session for the stock ...

Medtronic's Q2 results beat Wall Street expectations, with revenue up 5% year-over-year. Click here to find out why I have a ...

Bank of America Securities analyst Travis Steed maintained a Buy rating on Medtronic (MDT – Research Report) today. The company’s shares opened ...

Medtronic plc’s MDT growth in the fiscal second quarter of 2025 is backed by robust international expansion. The company’s ...

Shares of American-Irish medical devices company Medtronic PLC ($MDT) were in focus on Tuesday after the firm’s ...

As a long-term dividend investor, I've learned that the hardest part of investing isn't finding great companies -- it's ...

Shares of Medtronic PLC MDT inched 0.31% higher to $86.54 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.56% to 6,032.38 ...

Full-Year EPS Guidance: Raised to $5.44 to $5.50. Medtronic PLC (NYSE:MDT) reported a strong quarter with 5% organic revenue growth, translating into 8% EPS growth on a constant currency basis.

Galway: Medtronic plc has announced U.S. Food and Drug Administration (FDA) clearance for its new InPen app featuring missed ...

In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other Ken Griffin’s portfolio stocks to buy. Ken Griffin, the visionary founder of Citadel ...

Medtronic plc (MDT) announced earnings for its second quarter that increased from the same period last year and beat the Street ...

Medtronic plc and Tempus AI Inc. launched the ALERT study to better understand and address the racial, ethnic, gender and ...